SCHEMBL2896258

SCHEMBL2896258

O=C(Cl)c1cnc2ccsc2c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.43
MKNK1 Q9BUB5 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
ADORA2A P29274 3/20 0.38
ADORA2B P29275 1/20 0.38
PDPK1 O15530 1/20 0.38
PARP1 P09874 1/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ADORA1 P30542 1/20 0.33
DYRK1A Q13627 1/20 0.33
ALDH1A1 P00352 4/20 0.33
RAB9A P51151 2/20 0.33
NPC1 O15118 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
FADS1 O60427 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4900637 0.87 AXL (0.43) AXLMKNK1MKNK2ADORA2AADORA2B
SCHEMBL3977601 0.85 AXL (0.42) AXLMKNK1MKNK2PDPK1PARP1
SCHEMBL10474323 0.79 MEN1 (0.37) AXLMKNK1MKNK2MEN1KMT2A
SCHEMBL4904367 0.78 KMT2A (0.48) MEN1KMT2AALDH1A1RAB9ANPC1
SCHEMBL15654873 0.72 AXL (0.48) AXLMKNK1MKNK2ADORA2APDPK1
SCHEMBL3577404 0.72 AXL (0.48) AXLMKNK1MKNK2ADORA2APDPK1
SCHEMBL14266837 0.72 AXL (0.48) AXLMKNK1MKNK2ADORA2AADORA2B
SCHEMBL4543435 0.71 GPR35 (0.41) AXLMKNK1MKNK2ADORA2AADORA2B
SCHEMBL14266846 0.71 AXL (0.44) AXLMKNK1MKNK2ADORA2APDPK1
SCHEMBL10406124 0.71 KMT2A (0.41) AXLMKNK1MKNK2ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2202228-B1 AMIDE COMPOUNDS AND USE OF THE SAME TAKEDA PHARMACEUTICAL (JP) 2014-12-10 EP disclosed
US-8329691-B2 Amide compounds and use of the same TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-12-11 US disclosed
US-20100324010-A1 AMIDE COMPOUNDS AND USE OF THE SAME TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-23 US disclosed
EP-2202228-A1 AMIDE COMPOUNDS AND USE OF THE SAME Takeda Pharmaceutical Company Limited (JP) 2010-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324010-A1 AMIDE COMPOUNDS AND USE OF THE SAME REN, ACE, AGT AXL 2315/4885MKNK1 2051/4885MKNK2 2751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.